Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Active not recruiting 2Withdrawn 1Terminated 1Available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 17Leukemia, Myeloid, Acute 15Congenital Abnormalities 14Myelodysplastic Syndromes 13Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Multiple Myeloma 12Burkitt Lymphoma 12Lymphoma, Follicular 11Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 10Leukemia, Myeloid, Accelerated Phase 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hodgkin Disease 10Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Chronic-Phase 9Myeloproliferative Disorders 8Lymphoma, B-Cell, Marginal Zone 8Blast Crisis 8Neoplasms, Plasma Cell 7Lymphoma, Large-Cell, Immunoblastic 7Recurrence 6Myelodysplastic-Myeloproliferative Diseases 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Breast Neoplasms 6Sezary Syndrome 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Mycosis Fungoides 5

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00966498 2013-12-11

Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors

Emory University

Phase NA Terminated
3 enrolled

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡